Deep Track Capital, LP Portfolio Holdings
Deep Track Capital, LP
- $2.86 Billion
- Q1 2025
Deep Track Capital, LP has filed its 13F form on May 15, 2025 for Q1 2025 where it was disclosed a total value porftolio of $2.86 Billion distributed in 69 stocks.
Among their holdings, we can observe that their the top five positions include companies like: Intra Cellular Therapies, Inc. with a value of $264M, Immunovant, Inc. with a value of $261M, Guardant Health, Inc. with a value of $232M, Dynavax Technologies Corp with a value of $231M, and Protagonist Therapeutics, Inc with a value of $145M.
Examining the 13F form we can see an increase of $590M in the current position value, from $2.27B to 2.86B.
Deep Track Capital, LP is based out at Greenwich, CT
Below you can find more details about Deep Track Capital, LP portfolio as well as his latest detailed transactions.